Medical Patent News

RSS

Abviva to receive patent for its new Mammastatin technology

Abviva, Inc., a biomedical company engaged in the development and commercialization of breast cancer-related applications of Mammastatin, announced that the Canadian Patent Office issued notice that it will be issuing patent application Number 2.267.095 within 12 weeks

27 Jul 2010

Forest, Merz settle NAMENDA patent infringement litigation

Forest Laboratories, Inc. Forest Laboratories Holdings, Ltd., Merz Pharma GmbH & Co. KGaA, and Merz Pharmaceuticals GmbH announced today that they have entered into settlement agreements with all remaining defendants in patent infringement litigation related to Forest's NAMENDA® (memantine hydrochloride) immediate release tablets.

23 Jul 2010

Verify Brand granted US patent for 'Authentication and Tracking System'

Verify Brand announces it has received a United States patent (No. US 7,752,137 B2) for an "Authentication and Tracking System."

22 Jul 2010

Trinity receives USPTO Notice of Allowance for monoplanar pedicle screw method, system and kit

Trinity Orthopedics LLC, a medical device company that develops and markets products for minimally invasive spine surgery, announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a monoplanar pedicle screw method, system and kit. Trinity currently markets the posterior fixation system in the United States under the ReStor name.

22 Jul 2010

Applied Spine Technologies receives U.S. Patent for stabilization device with travel-limiting functionality

Applied Spine Technologies, a medical device company focused on motion preservation of the lumbar spine, received a Notice of Allowance on July 12, 2010 from the U.S. Patent and Trademark Office. To be clinically useful, a dynamic stabilization device needs to allow the spine to move, but not move excessively.

22 Jul 2010

Quick-Med Technologies receives USPTO Notice of Allowance for key NIMBUS antimicrobial technology patent

Quick-Med Technologies, Inc., a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announced today that the U.S. Patent and Trademark Office has issued a Notice of Allowance for a key patent related to the Company's proprietary NIMBUS® antimicrobial technology.

21 Jul 2010

USPTO approves patent for Avisena's system for managing accounts receivables

Avisena, a provider of revenue cycle management software and services for physician practices, today announced that the United States Patent and Trademark Office has approved a patent for the company's "system for managing accounts receivables."

21 Jul 2010

SANUWAVE receives European patent, exclusive rights for Shock Wave Generating Device

An emerging medical technology company focused on regenerative medicine, reports that the Company was granted European patent EP 1,452,141 entitled "Shock Wave Generating Device," which provides the Company exclusive rights in human and animal treatment devices that include the novel use of piezoelectric fibers to produce acoustic energy in the shock wave spectrum.

21 Jul 2010

Patent application for inexpensive CyPath assay filed by Biomoda

Cancer diagnostics company Biomoda,filed a U.S. patent application on a quantitative method for scoring cells labeled with the CyPath® assay to determine whether cells are dysplastic or carcinomic by measuring the photon emission rate.

21 Jul 2010

CSIRO signs global licensing agreement for Reversible Addition-Fragmentation chain Transfer technology

CSIRO has signed a global licensing agreement for its patented RAFT technology. Reversible Addition-Fragmentation chain Transfer (or RAFT) technology is an elegant and powerful polymerisation process that has given rise to a new branch of polymer chemistry.

21 Jul 2010

DBS signs exclusive license agreement with JLB

Decas Botanical Synergies, LLC. today announced that it has signed an Exclusive License Agreement with a purchase option with JLB, Inc. developer and owner of broad-based patents covering cranberry and other vaccinium species.

20 Jul 2010

U.S. District Court upholds validity of Nycomed's Protonix patent

Nycomed announced today that Judge Jose L. Linares of the U.S. District Court for the District of New Jersey has confirmed the jury verdict in favor of Nycomed and Pfizer Inc. The decision upholds the jury verdict issued on April 23, 2010, confirming that the patent is valid and rejecting allegations by the defendants that the patent was invalid as obvious and invalid for double patenting. Against KUDCo, the US generic drug business of the Schwarz Pharma Group, which did not at-risk launch, final Judgment was entered as a result of Judge Jose L. Linares' rulings.

19 Jul 2010

New Jersey District Court denies Teva's motion to overturn jury verdict in generic Protonix litigation

Teva Pharmaceutical Industries Ltd. announced today that the U.S. District Court for the District of New Jersey denied Teva's motion to overturn an April 23, 2010, jury verdict finding the patent in suit not invalid. The Court also denied Wyeth and Nycomed's request for FDA to reset the date of Teva's final approval to January 2011, based on the fact that Teva has patent defenses remaining at the District Court, including patent misuse.

17 Jul 2010

Ingen files patent to produce new drug insulin thermos product

Ingen Technologies, Inc. (Pink Sheets:IGNT), an emerging medical device manufacturer developing innovative solutions for the respiratory market, with a new patented and proprietary medical product line targeting the $8B respiratory market, announced today that the company has also filed a U.S patent and will begin the required manufacturing processes to produce the new drug insulin thermos product.

17 Jul 2010

Shrink Nanotechnologies files patent applications for CellAlign advanced tissue engineering technology

Shrink Nanotechnologies, Inc., an innovative nanotechnology company developing products and licensing opportunities in the solar energy production, medical diagnostics and sensors and biotechnology research and development tools businesses, announced today that certain patent applications related to its advanced tissue engineering technology platform, CellAlign™, have been filed.

15 Jul 2010

NovaBay Pharmaceuticals issued Notice of Allowance for broad portfolio of anti-infective compounds

NovaBay Pharmaceuticals, Inc. announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office on a patent application for a broad portfolio of anti-infective compounds, including NVC-612. The patent will broaden protection for NovaBay's first-in-class Aganocide family of compounds, which are designed to fight infections without causing drug resistance.

15 Jul 2010

Aduro BioTech announces issuance of two important patents

Aduro BioTech, a clinical-stage immunotherapy company, announced today the issuance of two important patents, the formation of a distinguished scientific advisory board, the addition of key members to its Board of Directors, and the reporting of preliminary top line long-term survival data from a Phase 1 clinical trial with 2 year follow-up.

15 Jul 2010

Two patents issued for GlycoMimetics lead drug candidate, related compounds

GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced that the U. S. Patent and Trademark Office has issued two patents covering the company's lead drug candidate and related compounds. One patent, US number 7,728,117, specifically covers GMI-1070, the Company's drug candidate now in clinical trials of patients with vaso-occlusive crisis of sickle cell disease. The second patent, US number 7,741,312, contains claims covering a family of molecules that includes and extends beyond GMI-1070.

15 Jul 2010

$Osseon receives notice of allowance for spinal vertebral compression fracture technology$

Osseon receives notice of allowance for spinal vertebral compression fracture technology

Osseon Therapeutics, Inc., a biomedical device company based in Santa Rosa, California, today received a notice of allowance for its spinal vertebral compression fracture (VCF) technology. The company which was started in 2006 has thirteen additional patent applications pending in the United States and throughout the world for related spinal therapies and devices. The lead inventor for this inaugural patent is Dr. Y. King Liu, one of three founders of Osseon.

15 Jul 2010

Gilead sues Lupin over Ranexa patent infringement

Gilead Sciences, Inc. today announced that it has filed a lawsuit in U.S. District Court in New Jersey against Lupin Limited for infringement against Gilead's patents for Ranexa® (ranolazine extended-release tablets). The lawsuit is based on an Abbreviated New Drug Application filed by Lupin, which seeks approval to manufacture and market a generic version of Ranexa before the expiration of Gilead's Ranexa patents.

15 Jul 2010

Medical Patent News

Abviva to receive patent for its new Mammastatin technology

Forest, Merz settle NAMENDA patent infringement litigation

Verify Brand granted US patent for 'Authentication and Tracking System'

Trinity receives USPTO Notice of Allowance for monoplanar pedicle screw method, system and kit

Applied Spine Technologies receives U.S. Patent for stabilization device with travel-limiting functionality

Quick-Med Technologies receives USPTO Notice of Allowance for key NIMBUS antimicrobial technology patent

USPTO approves patent for Avisena's system for managing accounts receivables

SANUWAVE receives European patent, exclusive rights for Shock Wave Generating Device

Patent application for inexpensive CyPath assay filed by Biomoda

CSIRO signs global licensing agreement for Reversible Addition-Fragmentation chain Transfer technology

DBS signs exclusive license agreement with JLB

U.S. District Court upholds validity of Nycomed's Protonix patent

New Jersey District Court denies Teva's motion to overturn jury verdict in generic Protonix litigation

Ingen files patent to produce new drug insulin thermos product

Shrink Nanotechnologies files patent applications for CellAlign advanced tissue engineering technology

NovaBay Pharmaceuticals issued Notice of Allowance for broad portfolio of anti-infective compounds

Aduro BioTech announces issuance of two important patents

Two patents issued for GlycoMimetics lead drug candidate, related compounds

Osseon receives notice of allowance for spinal vertebral compression fracture technology

Gilead sues Lupin over Ranexa patent infringement

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News